Cambridge Investment Research Advisors’s IQ ARB Merger Arbitrage ETF MNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Sell
15,865
-4,424
-22% -$161K ﹤0.01% 2621
2026
Q1
$738K Sell
20,289
-825
-4% -$29.8K ﹤0.01% 2445
2025
Q4
$756K Sell
21,114
-1,197
-5% -$42.9K ﹤0.01% 2337
2025
Q3
$801K Buy
22,311
+860
+4% +$30.6K ﹤0.01% 2231
2025
Q2
$757K Buy
21,451
+1,854
+9% +$64.3K ﹤0.01% 2174
2025
Q1
$672K Buy
19,597
+12,540
+178% +$422K ﹤0.01% 2176
2024
Q4
$233K Buy
7,057
+230
+3% +$7.56K ﹤0.01% 3062
2024
Q3
$224K Sell
6,827
-2,233
-25% -$72.4K ﹤0.01% 3053
2024
Q2
$286K Sell
9,060
-309
-3% -$9.62K ﹤0.01% 2740
2024
Q1
$295K Buy
9,369
+21
+0.2% +$659 ﹤0.01% 2716
2023
Q4
$294K Sell
9,348
-137
-1% -$4.3K ﹤0.01% 2612
2023
Q3
$300K Sell
9,485
-131
-1% -$4.11K ﹤0.01% 2493
2023
Q2
$300K Sell
9,616
-966
-9% -$30.4K ﹤0.01% 2524
2023
Q1
$335K Sell
10,582
-2,320
-18% -$72.9K ﹤0.01% 2396
2022
Q4
$409K Sell
12,902
-2,356
-15% -$74.1K ﹤0.01% 2184
2022
Q3
$477K Buy
15,258
+1,405
+10% +$44.4K ﹤0.01% 1974
2022
Q2
$429K Sell
13,853
-279
-2% -$8.78K ﹤0.01% 2076
2022
Q1
$451K Sell
14,132
-29,085
-67% -$926K ﹤0.01% 2195
2021
Q4
$1.39M Buy
43,217
+1,046
+2% +$34K 0.01% 1368
2021
Q3
$1.39M Buy
42,171
+4,420
+12% +$147K 0.01% 1307
2021
Q2
$1.26M Buy
37,751
+8,747
+30% +$292K 0.01% 1363
2021
Q1
$956K Sell
29,004
-9,081
-24% -$300K 0.01% 1457
2020
Q4
$1.27M Sell
38,085
-25,414
-40% -$862K 0.01% 1165
2020
Q3
$2.14M Buy
63,499
+57
+0.1% +$1.84K 0.01% 770
2020
Q2
$2M Sell
63,442
-35,216
-36% -$1.1M 0.02% 777
2020
Q1
$2.97M Sell
98,658
-138,708
-58% -$4.48M 0.03% 525
2019
Q4
$7.88M Buy
237,366
+74,168
+45% +$2.42M 0.06% 314
2019
Q3
$5.23M Sell
163,198
-4,370
-3% -$139K 0.05% 386
2019
Q2
$5.29M Sell
167,568
-44,040
-21% -$1.4M 0.05% 368
2019
Q1
$6.76M Buy
211,608
+80,105
+61% +$2.57M 0.06% 277
2018
Q4
$4.17M Buy
131,503
+41,988
+47% +$1.33M 0.05% 377
2018
Q3
$2.84M Sell
89,515
-13,107
-13% -$411K 0.03% 565
2018
Q2
$3.15M Buy
102,622
+15,071
+17% +$462K 0.03% 490
2018
Q1
$2.69M Buy
87,551
+46,507
+113% +$1.45M 0.03% 530
2017
Q4
$1.27M Sell
41,044
-2,037
-5% -$62.9K 0.02% 797
2017
Q3
$1.33M Sell
43,081
-6,368
-13% -$195K 0.02% 704
2017
Q2
$1.52M Buy
49,449
+7,083
+17% +$215K 0.02% 619
2017
Q1
$1.27M Buy
42,366
+15,794
+59% +$469K 0.02% 627
2016
Q4
$779K Sell
26,572
-864
-3% -$25.1K 0.01% 803
2016
Q3
$801K Buy
+27,436
New +$786K 0.01% 788
2016
Q1
Sell
-23,917
Closed -$671K 1635
2015
Q4
$671K Sell
23,917
-24,613
-51% -$683K 0.02% 725
2015
Q3
$1.35M Buy
48,530
+3,450
+8% +$97.9K 0.04% 398
2015
Q2
$1.29M Buy
45,080
+4,550
+11% +$132K 0.04% 428
2015
Q1
$1.17M Buy
+40,530
New +$1.15M 0.03% 456
2013
Q3
Sell
-11,440
Closed -$299K 1225
2013
Q2
$299K Buy
+11,440
New +$295K 0.02% 759

Other funds holding MNA

Cambridge Investment Research Advisors's MNA Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its IQ ARB Merger Arbitrage ETF (MNA) stake by 22% in Q2 2026, selling an estimated $161K and leaving 15,865 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #2621.

Cambridge Investment Research Advisors first reported a position in MNA in Q2 2013 and has held it in 45 quarters since. The position peaked at $7.88M in Q4 2019. 19 funds tracked by Wall St. Rank hold MNA as of Q2 2026.

  • Cambridge Investment Research Advisors held 15,865 shares of IQ ARB Merger Arbitrage ETF worth $579K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 4,424 IQ ARB Merger Arbitrage ETF shares in Q2 2026, an estimated $161K.
  • IQ ARB Merger Arbitrage ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2621 holding.
  • Cambridge Investment Research Advisors first reported a position in IQ ARB Merger Arbitrage ETF in Q2 2013 and has held it in 45 quarters since.
  • Cambridge Investment Research Advisors's IQ ARB Merger Arbitrage ETF position peaked at $7.88M in Q4 2019.
  • 19 funds tracked by Wall St. Rank held IQ ARB Merger Arbitrage ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.